Miglustat: substrate reduction therapy for lysosomal storage disorders associated with primary central nervous system involvement.

Recent patents on CNS drug discovery

Volumn 1, Issue 1, 2006, Pages 77-82

  Pastores, Gregory M ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 DEOXYNOJIRIMYCIN; DRUG DERIVATIVE; ENZYME INHIBITOR; MIGLUSTAT;

ANIMAL; BRAIN; BRAIN DISEASE; HUMAN; LYSOSOME STORAGE DISEASE; METABOLISM; REVIEW;

1-DEOXYNOJIRIMYCIN; ANIMALS; BRAIN; BRAIN DISEASES; ENZYME INHIBITORS; HUMANS; LYSOSOMAL STORAGE DISEASES;

EID: 39049168659     PISSN: 15748898     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488906775245282     Document Type: Review

References (34)